February 11, 2026 06:00 ET | Source: Upstream Bio – Verekitug provided statistically significant and clinically meaningful reductions in annualized…
BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed…
TAINAN, Feb. 10, 2026 /PRNewswire/ -- MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced positive…
DPTX3186, a first-in-class beta-catenin condensate modulator, received Orphan Drug Designation and Fast Track Designation from FDAClinical entry validates condensate modulator…
Initiation of trial marks first-in-human milestone for Neomorph’s novel molecular glue degrader platform February 03, 2026 13:08 ET | Source:…
February 03, 2026 13:06 ET | Source: Restem Initiation of the IIMPACT study follows promising Phase 1 results where Restem-L…
TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT study Unique sublingual formulation designed…
Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural…
First in class study of an investigational ACTH receptor antagonist aims to address significant unmet need in children and adolescents…
In 2026, AI investment is shifting from experimentation to deployment, with measurable ROI now a core requirement. Datatonic highlights the…